The Food and Drug Administration (FDA) approved a third over-the-counter version of naloxone nasal spray Tuesday, in a move the agency said could save lives and reduce costs. The agency approved another Rextovy, a 4 milligram naloxone nasal spray for the emergency treatment of opioid overdose. FDA said consumers may directly buy it in pharmacies, convenience stores and online. Naloxone is a…
Legacy kit behind vast majority of cyber attacks on utilities
With equipment and software poorly suited to withstand modern cyber threats, organizations need to do more to identify unmanaged or vulnerable systems
